ID   EV-SCC-14M
AC   CVCL_RK06
SY   EVSCC 14M; EVSCC14M; Eastern Virginia-Squamous Cell Carcinoma-14M
DR   Wikidata; Q54832951
RX   PubMed=8552396;
RX   PubMed=9815580;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
RX   PubMed=8552396;
RA   Patel A.M., Incognito L.S., Schechter G.L., Wasilenko W.J.,
RA   Somers K.D.;
RT   "Amplification and expression of EMS-1 (cortactin) in head and neck
RT   squamous cell carcinoma cell lines.";
RL   Oncogene 12:31-35(1996).
//
RX   PubMed=9815580;
RA   Wu Y.-G., Palad A.J., Wasilenko W.J., Blackmore P.F., Pincus W.A.,
RA   Schechter G.L., Spoonster J.R., Kohn E.C., Somers K.D.;
RT   "Inhibition of head and neck squamous cell carcinoma growth and
RT   invasion by the calcium influx inhibitor carboxyamido-triazole.";
RL   Clin. Cancer Res. 3:1915-1921(1997).
//
RX   PubMed=17312569; DOI=10.1002/hed.20478;
RA   Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L.,
RA   Koch W.M., Ferris R.L., Lai S.Y.;
RT   "Head and neck squamous cell carcinoma cell lines: established models
RT   and rationale for selection.";
RL   Head Neck 29:163-188(2007).
//